GSK

dynavax-reports-comparable-immune-response-for-shingles-vaccine

Dynavax Reports Comparable Immune Response for Shingles Vaccine

Editorial 21 August, 2025

Dynavax Technologies Corporation has announced that its experimental shingles vaccine demonstrated an immune response...

biontech-settles-mrna-patent-dispute-paving-path-for-gsk-and-curevac

BioNTech Settles mRNA Patent Dispute, Paving Path for GSK and CureVac

Editorial 8 August, 2025

BioNTech has reached a settlement in a lengthy mRNA patent dispute with GSK and...